Core Insights - Cannara Biotech Inc. has received preliminary acceptance from the Société Québécoise du Cannabis (SQDC) for five vape cartridge products, set to be distributed across all retail stores in Québec starting November 2025 [1][2] - The company aims to leverage its expertise in producing premium live resin vape cartridges, which have no additives, to establish a strong presence in the Québec market [2][4] Company Developments - Cannara Biotech operates two mega facilities in Québec, totaling over 1,650,000 sq. ft., with a potential annual cultivation output of 100,000 kg [6] - The company has positioned itself as Canada's leading premium live resin vape cartridge provider over the past year, focusing on high-quality formulations [2][4] Market Opportunity - The SQDC reported revenues of $741.5 million for the Québec market in 2024, indicating a significant opportunity for growth in the vape segment, which represents approximately 15% of total sales in other provinces [3] - A survey indicated that 25% of Québec consumers vaped in the past year, with 28% of those doing so at least weekly, highlighting a strong consumer base for vape products [3] Product Launch - Cannara's entry into the live rosin vape cartridge category represents a significant milestone, utilizing high-quality flower inputs that are grown and extracted in-house [4][5] - The launch is seen as a culmination of extensive research and development, focusing on genetic selection and process refinement [5]